Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Eiger Biopharmaceuticals
Eiger Biopharmaceuticals
(EIGR)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Zokinvy
Lonafarnib
2022-07-18
2023-2024
Progeria
,
Laminopathies
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lonafarnib
colorectal neoplasms
,
glioma
,
gliosarcoma
,
central nervous system neoplasms
,
nervous system neoplasms
,
neoplasms
,
sarcoma
,
astrocytoma
,
recurrence
,
supratentorial neoplasms
,
lymphoma
,
breast neoplasms
,
progeria
,
glioblastoma
,
head and neck neoplasms
,
prostatic neoplasms
,
ovarian neoplasms
,
bcr-abl positive chronic myelogenous leukemia
,
myeloid leukemia
,
chronic hepatitis
,
squamous cell carcinoma
,
squamous cell neoplasms
,
stomach neoplasms
,
liver diseases
,
ovarian epithelial carcinoma
,
carcinoma
,
squamous cell carcinoma of head and neck
,
liver neoplasms
,
urinary bladder neoplasms
,
kidney neoplasms
,
urethral neoplasms
,
transitional cell carcinoma
,
ureteral neoplasms
,
hepatitis d
,
hepatitis
,
chronic hepatitis d
,
hepatitis a
,
syndrome
,
lung neoplasms
,
leukemia
,
myelodysplastic syndromes
,
myelomonocytic leukemia chronic
,
myelomonocytic leukemia juvenile
,
preleukemia
,
non-small-cell lung carcinoma
,
neoplasm metastasis
,
virus diseases
,
laminopathies
Alfacalcidol
chronic renal insufficiency
,
kidney diseases
,
vitamin d deficiency
,
neoplasm metastasis
,
hyperparathyroidism
,
secondary hyperparathyroidism
Avexitide
hypoglycemia
,
congenital hyperinsulinism
,
nesidioblastosis
Sodium chloride
vomiting
,
nausea
Clemizole
hepatitis c
,
hepatitis
,
hepatitis a
Nepidermin
hypercholesterolemia
,
allergic rhinitis
,
rhinitis
,
asthma
,
hypertension
,
allergic rhinitis seasonal
,
allergic rhinitis perennial
,
hyperlipoproteinemia type ii
,
essential hypertension
,
infertility
,
fertilization in vitro
,
postoperative pain
,
osteoporosis
,
knee osteoarthritis
,
osteoarthritis
,
eczema
,
pruritus
,
dermatitis
,
chronic urticaria
,
urticaria
,
dysmenorrhea
,
toothache
,
schizophrenia
,
psychotic disorders
,
contraception
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
ankylosing spondylitis
,
spondylarthritis
,
spondylitis
,
rheumatoid arthritis
,
arthritis
Ubenimex
hypertension
,
pulmonary arterial hypertension
,
familial primary pulmonary hypertension
,
lymphedema
,
ischemic stroke
,
stroke
,
ischemia
,
chronic obstructive pulmonary disease
Fendrix
carcinoma
,
liver cirrhosis
,
hepatocellular carcinoma
Ebp921
hepatitis d
,
hepatitis
,
hepatitis a
Mevalotin
rheumatoid arthritis
,
arthritis
,
hepatitis c
,
healthy volunteers/patients
,
mucocutaneous lymph node syndrome
,
dyslipidemias
,
liver diseases
,
hypercholesterolemia
,
chronic renal insufficiency
,
kidney diseases
,
infections
,
acute coronary syndrome
Exendin9
healthy volunteers/patients
,
bariatric surgery
,
hyperglycemia
,
nutrition disorders
,
gastric emptying
,
digestive system physiological phenomena
,
gastrointestinal motility
,
gastric bypass
,
gastrectomy
,
congenital hyperinsulinism
,
nesidioblastosis
,
hyperinsulinism
,
dyspepsia
,
hypoglycemia
,
type 2 diabetes mellitus
,
diabetes mellitus
,
obesity
,
insulin secretion
,
prediabetic state
,
glucose metabolism disorders
,
metabolic diseases
,
kidney diseases
,
stomach neoplasms
,
dumping syndrome
,
morbid obesity
,
heart diseases
,
exploratory behavior
,
appetite regulation
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use